Ben Greener
About Ben Greener
Ben Greener is the Associate Director of Global Regulatory Sciences - CMC (Biologics) at Bristol Myers Squibb in Uxbridge, UK, with 20 years of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Ben Greener is the Associate Director of Global Regulatory Sciences CMC (Biologics) at Bristol Myers Squibb. He began his tenure at the global biopharmaceutical company in May 2021. Based in Uxbridge, UK, Ben plays a crucial role in overseeing regulatory strategies and ensuring compliance in the area of Chemistry, Manufacturing, and Controls (CMC) for biologics.
Career at Celgene
Ben Greener worked at Celgene for six years, holding multiple positions in the Global Regulatory CMC division. From 2017 to 2021, he served as a Senior Manager, Global Regulatory CMC (Biologics). Prior to that, from 2015 to 2017, he was Manager, Global Regulatory CMC (International Region). Both roles were based in Uxbridge, UK, and involved substantial responsibilities in regulatory compliance and oversight.
Experience at PAREXEL Consulting
Ben Greener spent four years at PAREXEL Consulting, where he ascended from the rank of Associate to Consultant. His tenure at the consulting firm spanned from 2011 to 2015 in Uxbridge, UK. During this period, he gained valuable experience in providing consultancy services, focusing on regulatory affairs and compliance within the pharmaceutical industry.
Extensive Work at Pfizer
Ben Greener dedicated a decade of his career to Pfizer, starting as a Research Associate in 2001 and advancing to Senior Scientist by 2011. His roles at the Sandwich, UK location included Scientist and Senior Scientist, and involved significant research and development in the pharmaceutical sector. His time at Pfizer marked a period of professional growth and deepening expertise in scientific research.
Educational Background and Certifications
Ben Greener holds an MChem degree in Chemistry from The University of Sheffield, where he studied from 1997 to 2001. He also completed an industrial traineeship as a Process Chemist at AstraZeneca from 1999 to 2000. Additionally, Ben is a Certified Regulatory Affairs Professional (RAC certified), specializing in Chemistry, Manufacturing, and Controls (CMC), which underscores his commitment to regulatory excellence.